A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, completely eradicating tumors in certain preclinical models. Targeting the well-defined and accessible biomarker claudin-18.2,…
Continue Reading
News Source: medicalxpress.com
Leave a Reply